trolamine salicylate has been researched along with Demyelinating Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreyer, L; Locht, H; Magyari, M; Theibich, A | 1 |
| Scheinfeld, N | 1 |
| Baumgartner, SW; Fleischmann, R; Liu, T; Peloso, P; Weisman, MH; White, B | 1 |
| Cakci, A; Eksioglu, E; Karadavut, IK; Keyik, B; Oztekin, F; Unlu, E | 1 |
| Lisak, RP | 1 |
| Court, SD; Ditchburn, RK; Gardner, PS; McQuillin, J | 1 |
2 review(s) available for trolamine salicylate and Demyelinating Diseases
| Article | Year |
|---|---|
Adalimumab: a review of side effects.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis; Demyelinating Diseases; Exanthema; Heart Failure; Humans; Infections; Injections, Subcutaneous; Lupus Vulgaris; Psoriasis; Risk Factors; Spondylitis, Ankylosing; Syndrome; Tuberculosis | 2005 |
Long term safety of etanercept in elderly subjects with rheumatic diseases.
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cardiovascular Diseases; Clinical Trials as Topic; Demyelinating Diseases; Etanercept; Humans; Immunoglobulin G; Middle Aged; Neoplasms; Opportunistic Infections; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2006 |
4 other study(ies) available for trolamine salicylate and Demyelinating Diseases
| Article | Year |
|---|---|
Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cohort Studies; Demyelinating Diseases; Etanercept; Female; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Infliximab; Male; Methotrexate; Middle Aged; Nervous System Diseases; Outpatients; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Sacroiliitis and polyneuropathy during isotretinoin treatment.
Topics: Acne Vulgaris; Adult; Arthritis; Demyelinating Diseases; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Isotretinoin; Male; Polyneuropathies; Radiography; Sacroiliac Joint; Treatment Outcome; Withholding Treatment | 2008 |
Arthritis associated with circulating immune complexes following administration of intravenous immunoglobulin therapy in a patient with chronic inflammatory demyelinating polyneuropathy.
Topics: Antigen-Antibody Complex; Arthritis; Chronic Disease; Demyelinating Diseases; Female; Humans; Immunoglobulins, Intravenous; Middle Aged; Peripheral Nervous System Diseases; Serum Sickness | 1996 |
Respiratory syncytial virus in hospital cross-infection.
Topics: Arthritis; Bronchiolitis, Viral; Child, Preschool; Common Cold; Cross Infection; Demyelinating Diseases; Female; Gastroenteritis; Hospital Design and Construction; Humans; Infant; Infant Nutrition Disorders; Male; Melena; Meningitis; Motor Neurons; Muscular Atrophy; Paralysis; Respiratory Syncytial Viruses; Respiratory Tract Infections; Spinal Cord Diseases; Urinary Tract Infections | 1971 |